Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome
2011

Neutral Variant in MLH1 for Lynch Syndrome

Sample size: 1034 publication Evidence: high

Author Information

Author(s): Adela Castillejo, Carla Guarinos, Ana Martinez-Canto, Victor-Manuel Barbera, Cecilia Egoavil, Maria-Isabel Castillejo, Lucia Perez-Carbonell, Ana-Beatriz Sanchez-Heras, Angel Segura, Enrique Ochoa, Rafael Lazaro, Clara Ruiz-Ponte, Luis Bujanda, Montserrat Andreu, Antoni Castells, Angel Carracedo, Xavier Llor, Juan Clofent, Cristina Alenda, Artemio Paya, Rodrigo Jover, Jose-Luis Soto

Primary Institution: Hospital Universitario Elche

Hypothesis

Is the c.1852_1853AA>GC variant in MLH1 a neutral variant for Lynch syndrome?

Conclusion

The p.Lys618Ala variant should be considered a neutral variant for Lynch syndrome.

Supporting Evidence

  • The p.Lys618Ala variant was found in 27 individuals, with no significant associations in case-control studies.
  • Only two positive cases of microsatellite instability were detected in tumours from p.Lys618Ala carriers.
  • The variant co-existed with pathogenic mutations in two unrelated Lynch syndrome families.

Takeaway

This study found that a specific gene variant does not cause Lynch syndrome, which means it doesn't increase cancer risk.

Methodology

Genotyping of the p.Lys618Ala variant was performed in 1034 individuals, including sporadic and familial colorectal cancer patients and controls.

Limitations

The study may not account for all genetic backgrounds and environmental factors that could influence cancer risk.

Participant Demographics

The median age of sporadic CRC patients was 70 years, with a sex distribution of 58% men and 42% women.

Digital Object Identifier (DOI)

10.1186/1471-2350-12-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication